i-Seq Biotechnology
PrivateLast Round
Grant
Jun 9, 2026
Total Funding Raised
$10,000
Company Overview
i-Seq Biotechnology is a biotechnology company that develops novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i-Seq Biotechnology Comparables
Compare i-Seq Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNewVax Ltd. | 80% | |
| Abera Bioscience | 61% | |
| Pfizer | 60% | |
i-Seq Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2026 | ||||
| Seed | Oct 15, 2024 |
Key People
Founding team and executive leadership
i-Seq Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
| VIC Investor Network | Seed |
i-Seq Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about i-Seq Biotechnology's valuation, stock price, and market status.